EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events and hospitalizations: a cluster-randomized controlled trial

Ramón Paniagua, Alfonso Ramos, Marcela Ávila iD, María-de-Jesús Ventura, Armando Nevarez-Sida, Abdul Rashid Qureshi iD, Bengt Lindholm, Mexican Nephrology Collaborative Study Group

Nephrology Dialysis Transplantation · 2025

DOI: 10.1093/ndt/gfae188 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Ramón Paniagua und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación Médica en Enfermedades Nefrológicas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seg…. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Hospitalization, Kidney Failure, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baxter, Fundación IMSS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Remote monitoring (RM) of patients on automated peritoneal dialysis (APD) prevents complications and improves treatment quality. We analyzed the effect of RM-APD on mortality and complications related to cardiovascular disease, fluid overload and insufficient dialysis efficiency.

Methods

In a cluster-randomized, open-label, controlled trial, 21 hospitals with APD programs were assigned to use either RM-APD (10 hospitals; 403 patients) or conventional APD (11 hospitals; 398 patients) for the treatment of adult patients starting PD. Primary outcomes were time to first event of: (i) Composite Index 1 comprising all-cause mortality, first adverse events and hospitalizations of any cause, and (ii) Composite Index 2 comprising cardiovascular mortality, first adverse event and hospitalizations related to cardiovascular disease, fluid overload and insufficient dialysis efficiency. Secondary outcomes were time to first event of individual components of the two composite indices, and rates of adverse events, hospitalizations, unplanned visits and transfer to hemodialysis. Patients were followed for a median of 9.5 months. Primary outcomes were evaluated by competing risk analysis and restricted mean survival time (RMST) analysis.

Results

While time to reach Composite Index 1 did not differ between the groups, Composite Index 2 was reached earlier (ΔRMST: –0.86 months; P = .02), and all-cause mortality [55 vs 33 deaths, P = .01; sub-hazard ratio (sHR) 1.69 (95% confidence interval 1.39–2.05), P < .001] and hospitalizations of any cause were higher in APD group than in RM-APD as were cardiovascular deaths [24 vs 13 deaths, P = .05; sHR 2.44 (95% confidence interval 1.72–3.45), P < .001] and rates of adverse events and hospitalizations related to cardiovascular disease, fluid overload or insufficient dialysis efficiency. Dropouts were more common in the APD group (131 vs 110, P = .048).

Conclusions

This randomized controlled trial shows that RM may add significant advantages to APD, including improved survival and reduced rate of adverse events and hospitalizations, which can favorably impact the acceptance and adoption of the therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal DialysisHospitalizationKidney Failure, ChronicCardiovascular DiseasesHumansMaleFemaleMiddle AgedAgedSurvival RateFollow-Up StudiesMonitoring, PhysiologicPrognosisAdult

Stichwörter der Autor:innen

adverse eventsautomated peritoneal dialysiscluster randomized control trialmortalityremote patient monitoring

Autor:innen und Institutionen

  • Unidad de Investigación Médica en Enfermedades Nefrológicas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.
  • Macrotech, Mexico City, Mexico.
  • Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Marcela Ávila, Abdul Rashid Qureshi

Förderung

  • Baxter
  • Fundación IMSS

Zitieren

APA

Paniagua, R., Ramos, A., Ávila, M., Ventura, M. D., Nevarez-Sida, A., Qureshi, A. R., Lindholm, B., & Mexican Nephrology Collaborative Study Group (2025). Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events and hospitalizations: a cluster-randomized controlled trial. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfae188

Vancouver

Paniagua R, Ramos A, Ávila M, Ventura MD, Nevarez-Sida A, Qureshi AR, et al. Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events and hospitalizations: a cluster-randomized controlled trial. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfae188

BibTeX
@article{Paniagua2025,
  author = {Paniagua, Ramón and Ramos, Alfonso and Ávila, Marcela and Ventura, María-de-Jesús and Nevarez-Sida, Armando and Qureshi, Abdul Rashid and Lindholm, Bengt and Mexican Nephrology Collaborative Study Group, Mexican Nephrology Collaborative Study Group},
  title = {Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events and hospitalizations: a cluster-randomized controlled trial},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  doi = {10.1093/ndt/gfae188}
}
Kostenlos starten →